Samsung Biologics, a global contract development and manufacturing organization (CDMO), appointed Gail Ward executive vice president and head of the quality center, and Sojeong Lee vice president and head of regulatory affairs. A veteran pharmaceutical executive, Ward has almost four decades of extensive quality experience in both large pharmaceutical companies and entrepreneurial biotech companies. Prior to joining Samsung Biologics, Ward served as head of quality at ProKidney Corporation, a...